Mark E. Sims insider trades
Open-market stock purchases and sales by Mark E. Sims, Chief Commercial Officer at Candel Therapeutics, Inc, from SEC Form 4 filings since Jul 6, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 6, 2026 | CADL Candel Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- CADL Candel Therapeutics, Inc: other filings, last Jul 6, 2026